Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis
Authors:
- 19 May 2011
- journal article
- Published by Taylor & Francis in Growth Factors
- Vol. 29 (4) , 119-127
Abstract
To understand the molecular pathogenesis of oral submucous fibrosis (OSF), which is a chronic inflammatory disease, gene expression profiling was performed in 10 OSF tissues against 8 pooled normal tissues using oligonucleotide arrays. Microarray results revealed differential expression of 5288 genes (P ≤ 0.05 and fold change ≥ 1.5). Among these, 2884 are upregulated and 2404 are downregulated. Validation employing quantitative real-time PCR and immunohistochemistry confirmed upregulation of transforming growth factor-β1 (TGF-β1), TGFBIp, THBS1, SPP1, and TIG1 and downregulation of bone morphogenic protein 7 (BMP7) in OSF tissues. Furthermore, activation of TGF-β pathway was evident in OSF as demonstrated by pSMAD2 strong immunoreactivity. Treatment of keratinocytes and oral fibroblasts by TGF-β confirmed the regulation of few genes identified in microarray including upregulation of connective tissue growth factor, TGM2, THBS1, and downregulation of BMP7, which is a known negative modulator of fibrosis. Taken together, these data suggest activation of TGF-β signaling and suppression of BMP7 expression in the manifestation of OSF.Keywords
This publication has 23 references indexed in Scilit:
- Areca nut in pathogenesis of oral submucous fibrosis: revisitedOral and Maxillofacial Surgery, 2010
- Role of endothelin in lung fibrosisEuropean Respiratory Review, 2008
- Discovery of Novel Biomarkers in Oral Submucous Fibrosis by Microarray AnalysisCancer Epidemiology, Biomarkers & Prevention, 2008
- BMP-7 opposes TGF-β1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2American Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Pathogenesis of fibrosis: role of TGF-β and CTGFCurrent Opinion in Rheumatology, 2002
- TGFβ/Smad signaling system and its pathologic correlatesAmerican Journal of Medical Genetics Part A, 2002
- Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)Journal of Biological Chemistry, 2001
- Oral submucous fibrosis patients have altered levels of cytokine productionJournal of Oral Pathology & Medicine, 2000
- Oral stent as treatment adjunct for oral submucous fibrosisOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1996
- Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.Journal of Cell Biology, 1989